Read More Pharma Industry News FDA approves expansive label updates for Esperion’s NEXLETOL and NEXLIZET In a significant advancement for heart health management, Esperion (NASDAQ: ESPR) has announced that the United States Food… byPallavi MadhirajuMarch 23, 2024